The Allstate Co. (NYSE:ALL) Shares Bought by Janus Henderson Group PLC

Janus Henderson Group PLC increased its stake in The Allstate Co. (NYSE:ALL) by 1.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 32,315 shares of the insurance provider’s stock after purchasing an additional 347 shares during the quarter. Janus Henderson Group PLC’s holdings in Allstate were worth $6,127,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ALL. OFI Invest Asset Management acquired a new position in shares of Allstate during the second quarter valued at approximately $476,000. Eagle Asset Management Inc. increased its position in shares of Allstate by 38.0% during the 3rd quarter. Eagle Asset Management Inc. now owns 10,497 shares of the insurance provider’s stock valued at $2,067,000 after purchasing an additional 2,888 shares during the period. Bank of Montreal Can raised its stake in shares of Allstate by 1.7% in the 3rd quarter. Bank of Montreal Can now owns 683,574 shares of the insurance provider’s stock worth $128,758,000 after buying an additional 11,195 shares in the last quarter. Diversified Trust Co lifted its holdings in shares of Allstate by 505.3% in the second quarter. Diversified Trust Co now owns 7,923 shares of the insurance provider’s stock valued at $1,265,000 after buying an additional 6,614 shares during the period. Finally, Hsbc Holdings PLC boosted its stake in Allstate by 3.3% during the second quarter. Hsbc Holdings PLC now owns 1,007,953 shares of the insurance provider’s stock valued at $160,948,000 after buying an additional 31,789 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.

Insider Buying and Selling at Allstate

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the transaction, the insider now owns 27,364 shares in the company, valued at $5,236,922.32. This trade represents a 57.06 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 1.80% of the company’s stock.

Allstate Stock Performance

Shares of ALL stock opened at $199.05 on Tuesday. The Allstate Co. has a fifty-two week low of $134.17 and a fifty-two week high of $209.88. The stock’s 50-day moving average is $194.59 and its two-hundred day moving average is $180.71. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40. The firm has a market cap of $52.71 billion, a P/E ratio of 12.89, a PEG ratio of 1.79 and a beta of 0.50.

Allstate (NYSE:ALL) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, beating the consensus estimate of $2.20 by $1.71. The firm had revenue of $16.63 billion for the quarter, compared to analyst estimates of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The company’s revenue for the quarter was up 14.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.81 earnings per share. Analysts predict that The Allstate Co. will post 16.26 earnings per share for the current fiscal year.

Allstate Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be issued a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 1.85%. The ex-dividend date is Friday, November 29th. Allstate’s dividend payout ratio is presently 23.83%.

Wall Street Analyst Weigh In

ALL has been the subject of several research reports. Roth Mkm restated a “buy” rating and set a $200.00 price objective on shares of Allstate in a research report on Wednesday, August 14th. Keefe, Bruyette & Woods raised their target price on shares of Allstate from $222.00 to $225.00 and gave the stock an “outperform” rating in a report on Wednesday, November 6th. Morgan Stanley increased their price objective on Allstate from $220.00 to $228.00 and gave the company an “overweight” rating in a research report on Thursday, November 7th. StockNews.com cut Allstate from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 21st. Finally, Barclays upped their target price on Allstate from $175.00 to $187.00 and gave the company an “underweight” rating in a report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Allstate has a consensus rating of “Moderate Buy” and an average target price of $217.19.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.